Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
Adair Smith G, Dunlop A, Alexander SE, Barnes H, Casey F, Chick J, Gunapala R, Herbert T, Lawes R, Mason SA, Mitchell A, Mohajer J, Murray J, Nill S, Patel P, Pathmanathan A, Sritharan K, Sundahl N, Tree AC, Westley R, Williams B, McNair HA. Adair Smith G, et al. Radiother Oncol. 2023 Mar;180:109457. doi: 10.1016/j.radonc.2022.109457. Epub 2023 Jan 3. Radiother Oncol. 2023. PMID: 36608770 Free PMC article.
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI.
Adair Smith G, Dunlop A, Alexander SE, Barnes H, Casey F, Chick J, Gunapala R, Herbert T, Lawes R, Mason SA, Mitchell A, Mohajer J, Murray J, Nill S, Patel P, Pathmanathan A, Sritharan K, Sundahl N, Westley R, Tree AC, McNair HA. Adair Smith G, et al. Tech Innov Patient Support Radiat Oncol. 2022 Dec 30;25:100200. doi: 10.1016/j.tipsro.2022.12.007. eCollection 2023 Mar. Tech Innov Patient Support Radiat Oncol. 2022. PMID: 36654720 Free PMC article.
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey.
Boldrini L, Alongi F, Romano A, Charles Davies D, Bassetti M, Chiloiro G, Corradini S, Gambacorta MA, Placidi L, Tree AC, Westley R, Nicosia L. Boldrini L, et al. Clin Transl Radiat Oncol. 2023 Mar 8;40:100615. doi: 10.1016/j.ctro.2023.100615. eCollection 2023 May. Clin Transl Radiat Oncol. 2023. PMID: 36968577 Free PMC article.
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Westley RL, Biscombe K, Dunlop A, Mitchell A, Oelfke U, Nill S, Murray J, Pathmanathan A, Hafeez S, Parker C, Ratnakumaran R, Alexander S, Herbert T, Hall E, Tree AC. Westley RL, et al. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):682-687. doi: 10.1016/j.ijrobp.2023.09.032. Epub 2023 Sep 29. Int J Radiat Oncol Biol Phys. 2024. PMID: 37776979 Free article.
Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
Westerhoff JM, Daamen LA, Christodouleas JP, Blezer ELA, Choudhury A, Westley RL, Erickson BA, Fuller CD, Hafeez S, van der Heide UA, Intven MPW, Kirby AM, Lalondrelle S, Minsky BD, Mook S, Nowee ME, Marijnen CAM, Orrling KM, Sahgal A, Schultz CJ, Faivre-Finn C, Tersteeg RJHA, Tree AC, Tseng CL, Schytte T, Silk DM, Eggert D, Luzzara M, van der Voort van Zyp JRN, Verkooijen HM, Hall WA. Westerhoff JM, et al. Among authors: westley rl. JAMA Netw Open. 2024 May 1;7(5):e2410819. doi: 10.1001/jamanetworkopen.2024.10819. JAMA Netw Open. 2024. PMID: 38691356 Free PMC article.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.
Westley R, Casey F, Mitchell A, Alexander S, Nill S, Murray J, Ratnakumaran R, Pathmanathan A, Oelfke U, Dunlop A, Tree AC. Westley R, et al. Cancers (Basel). 2024 May 30;16(11):2073. doi: 10.3390/cancers16112073. Cancers (Basel). 2024. PMID: 38893193 Free PMC article.
13 results